Encompass Health
323 hedge funds and large institutions have $4.32B invested in Encompass Health in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 150 increasing their positions, 93 reducing their positions, and 37 closing their positions.
2,027% more call options, than puts
Call options by funds: $10.5M | Put options by funds: $492K
61% more repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 93
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
4% less capital invested
Capital invested by funds: $4.51B → $4.32B (-$196M)
3% less funds holding
Funds holding: 333 → 323 (-10)
12.39% less ownership
Funds ownership: 130.94% → 118.55% (-12%)
14% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 37
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.9M |
| 2 |
BlackRock
New York
|
+$46.5M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
+$26.2M |
| 4 |
SAM
Senzar Asset Management
New York
|
+$20.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$12.7M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$46.4M |
| 2 |
MSL
Mackay Shields LLC
New York
|
-$39.6M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$27.1M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$20.1M |
| 5 |
Comerica Bank
Dallas,
Texas
|
-$18.4M |
EHC Hedge Fund Activity: Q3 2017 in Review
323 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q3 2017, worth a combined $4.32B — down 4.3% from $4.51B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of EHC and 32 opened new positions — a net loss of 5 holders — while 93 trimmed existing stakes and 150 added.
The largest buyer was Vanguard Group, adding an estimated $56.9M. The largest seller was Invesco, cutting an estimated $46.4M.
- 323 institutional investors held Encompass Health (EHC) as of Q3 2017, down from 333 in Q2 2017.
- Funds reported $4.32B of Encompass Health stock for Q3 2017, down 4.3% quarter-over-quarter.
- 32 funds opened new Encompass Health positions in Q3 2017 and 37 closed out, a net change of -5 holders.
- The largest Encompass Health buyer in Q3 2017 was Vanguard Group, an estimated $56.9M added.
- The largest Encompass Health seller in Q3 2017 was Invesco, an estimated $46.4M sold.
Based on aggregated 13F filings for Q3 2017.